Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

North America Bioregenerative Aesthetic Injectable Companies and Strategic Involvements

Date : 03 July 2026

Top Companies in the North America bioregenerative aesthetic injectable Market & Their Offerings

North America Bioregenerative Aesthetic Injectable Market Companies are AbbVie / Allergan Aesthetics, Merz Aesthetics, Revance Therapeutics, Evolus, Inc., Prollenium Medical Technologies, Sinclair North America, Benev Company, Inc., Crown Aesthetics

Market Ecosystem Analysis

Ecosystem Segment Key Participants Explanation
Technology Providers Merz Aesthetics, Galderma, Sinclair Pharma, Croma-Pharma Develop collagen-stimulating biomaterials and injectable technologies.
Product Manufacturers Galderma, Merz Aesthetics, AbbVie (Allergan Aesthetics), Revance Therapeutics, Suneva Medical Manufacture commercial regenerative injectable products.
Service Providers Dermatology clinics, Plastic surgery centers, Medical spas Deliver injectable aesthetic procedures to patients.
Platform Providers Crown Laboratories, Evolus, Revance Therapeutics Offer integrated aesthetic portfolios combining injectables with complementary products.
CROs/CDMOs ICON plc, Charles River Laboratories, Thermo Fisher Scientific (Patheon) Support clinical development and manufacturing of injectable biologics and medical aesthetics products.
Software Vendors Nextech Systems, PatientNow, Symplast Practice management, imaging, treatment planning, and patient engagement platforms.
Research Institutions Mayo Clinic, Cleveland Clinic, Stanford University, University of California System Conduct regenerative medicine and aesthetic clinical research.
End-User Industries Medical aesthetics, Cosmetic dermatology, Plastic surgery, Ambulatory surgical centers Primary healthcare sectors utilizing regenerative injectable therapies.

What are the Recent Developments in the North America bioregenerative aesthetic injectable Market?

  • In October 2025, Croma-Pharma entered into a distribution partnership with Renellence to expand its presence in Canada’s aesthetics market. Under this agreement, Renellence will commercialize Croma’s MDR-approved Saypha hyaluronic acid filler portfolio in the country, while both companies will also work together on physician education, training initiatives, and broader long-term market development efforts.
  • In June 2025, Galderma revealed plans to establish a new U.S. headquarters in Miami to support faster innovation and business expansion in its largest market. The Brickell-based office is expected to accommodate around 150 employees by 2028 and will reinforce the company’s position in skincare and injectable aesthetics, while Galderma continues to maintain its broader network of operations across the United States.

Competitive Landscape

Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Galderma Zug Switzerland Global leader in injectable aesthetics with strong North American presence Sculptra®, Restylane® portfolio
Merz Aesthetics Raleigh, North Carolina United States Leading collagen stimulator manufacturer Radiesse®, Belotero®
AbbVie (Allergan Aesthetics) North Chicago, Illinois United States Dominant aesthetic injectable portfolio and physician network Juvéderm®, Skinvive™
Revance Therapeutics Nashville, Tennessee United States Expanding injectable aesthetics portfolio in North America RHA® Collection, DAXXIFY®
Sinclair Pharma London United Kingdom Global regenerative injectable specialist with North American commercialization Lanluma®, Ellansé® (outside U.S.), regenerative aesthetics portfolio
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Suneva Medical San Diego, California United States Pioneer in regenerative aesthetics Bellafill®
Croma-Pharma Leobendorf Austria Growing collagen-stimulating and HA injectable portfolio entering North America Saypha®, regenerative aesthetic solutions
Evolus Newport Beach, California United States Rapidly expanding aesthetics portfolio beyond neurotoxins Estyme® (licensed HA fillers), aesthetic injectables
Crown Laboratories Johnson City, Tennessee United States Building integrated physician aesthetic platform SkinPen®, aesthetic regenerative portfolio
Hans Biomed Seoul South Korea Active supplier of regenerative biomaterials and aesthetic injectables in international markets including North America through partnerships Dermal fillers and regenerative biomaterials
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services
Rion Aesthetics Rochester, Minnesota United States Developer of platelet-derived regenerative aesthetic biologics Platelet-derived exosome-inspired regenerative injectables
AestheFill (REGEN Biotech) Seongnam South Korea Commercial collagen stimulator expanding globally AestheFill® PLLA collagen stimulator
ExoCoBio Seoul South Korea Developer of exosome-based regenerative aesthetic technologies Exosome regenerative skin products
Benev Company Mission Viejo, California United States Active in regenerative aesthetics with PRP and regenerative solutions Growth factor and regenerative injectable products
Kimera Labs Miramar, Florida United States Regenerative biologics company supporting aesthetic regenerative medicine Perinatal-derived regenerative biologics

Market Growth

The North America bioregenerative aesthetic injectable market size was estimated at USD 1.49 billion in 2025 and is predicted to increase from USD 1.69 billion in 2026 to approximately USD 5.15 billion by 2035, expanding at a CAGR of 13.20% from 2026 to 2035.

North America Bioregenerative Aesthetic Injectable Market Size is USD 1.69 Billion in 2026.

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales